Clinical Trial Update: Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating quercetin for chemoprevention of squamous cell carcinoma in patients with Fanconi anemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fanconi Anemia
• Squamous Cell Carcinoma

Drugs mentioned

• Quercetin (quercetin)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Fanconi Anemia, Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2026-04-20